股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致：香港交易及結算所有限公司 公司名稱: 成志控股有限公司 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01741 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 本月底法定/註冊股本總額： HKD 20,000,000 F ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | 狀態: | 新提交 | | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | 公司名稱: | 成志控股有限公司 | | | | 呈交日期: | 2025年10月2日 | | | | I. 法定/註冊股本變動 | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01741 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 2,0 ...

本程序以英文製作，如若中英文版本出現差異或不一致，應以英文版本為準。 SHING CHI HOLDINGS LIMITED 成志控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：1741） （「本公司」） 提名委員會 職權範圍 提名委員會（「本委員會」）的職權範圍是根據香港聯合交易所有限公司證券上市規則（分別為「聯交所」 及「上市規則」）相關要求制訂。 組成 權限 職責 2 6. 每年舉行的會議須至少一次。如本委員會的工作需要時，應該舉行額外會議。 7. 會議的法定人數為本委員會兩名成員。 8. 本委員會成員可以親身出席、電話或視像會議之形式參與會議。 9. 本委員會的決議案應當由本委員會成員的過半數通過。 10. 所有本委員會成員共同簽署之書面決議案與正式召開之委員會會議上通過之決議案同樣有效。 11. 除本文另有規定外，本委員會的會議程序受組織章程細則的相關條文（不時予以修訂）規限。 1. 本委員會乃本公司董事會（「董事」或「董事會」）根據本公司組織章程細則（「組織章程細則」）規定， 於本公司股份於聯交所上市之日起正式成立。 成員 秘書 5. 本委員會的秘書由本公司的公司秘書或由本委員會委任任何 ...

第 1 頁 共 10 頁 v 1.1.1 | 截至月份: | 2025年8月31日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | | | | 公司名稱: | 成志控股有限公司 | | | | | | 呈交日期: | 2025年9月1日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 01741 | 說明 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | ...

致：香港交易及結算所有限公司 公司名稱: 成志控股有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01741 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.01 | HKD | | 20,000,000 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 2025年7月31日 狀態: 新提交 | | --- | | 截至月份 ...

中期報告 2025 INTERIM REPORT 2025 中期報告 目錄 | 公司資料 | 2 | | --- | --- | | 中期未經審核簡明綜合損益及其他全面收益表 | 4 | | 中期未經審核簡明綜合財務狀況表 | 6 | | 中期未經審核簡明綜合權益變動表 | 8 | | 中期未經審核簡明綜合現金流量表 | 10 | | 中期未經審核簡明綜合財務報表附註 | 11 | | 管理層討論及分析 | 28 | | 其他資料 | 41 | 公司資料 董事會 執行董事 劉志宏博士 （主席） 劉志明先生 劉志強博士 （行政總裁） 劉恩琪女士 獨立非執行董事 梁秉綱先生 彭嘉恆先生 黃鎮南先生 董事委員會 審核委員會 彭嘉恆先生 （主席） 梁秉綱先生 黃鎮南先生 薪酬委員會 黃鎮南先生 （主席） 劉志明先生 梁秉綱先生 彭嘉恆先生 提名委員會 梁秉綱先生 （主席） 劉志強博士 彭嘉恆先生 黃鎮南先生 劉恩琪女士 （於二零二五年三月十九日獲委任） 投資委員會 劉志明先生 （主席） 劉志宏博士 劉志強博士 梁秉綱先生 彭嘉恆先生 黃鎮南先生 公司秘書 嚴秀屏女士 授權代表 劉志明先生 嚴秀屏女士 開曼群島註冊辦事 ...

Financial Performance - The company reported revenue of HKD 85,538,000 for the six months ended March 31, 2025, representing a 14% increase from HKD 75,075,000 in the same period of 2024[3]. - Gross profit decreased to HKD 3,695,000, down 33% from HKD 5,543,000 year-on-year[3]. - Operating loss improved to HKD 6,894,000, compared to a loss of HKD 8,268,000 in the previous year, indicating a 16.6% reduction in losses[3]. - The total comprehensive loss for the period was HKD 6,964,000, significantly lower than HKD 16,818,000 in the prior year[4]. - Basic and diluted loss per share from continuing operations was HKD 0.87, compared to HKD 1.05 in the previous year[4]. - The company reported a pre-tax loss of HKD 6,964,000 for the six months ended March 31, 2025, compared to a pre-tax loss of HKD 16,637,000 for the same period in 2024, indicating an improvement in financial performance[23]. - The group recorded a net loss of approximately HKD 8.3 million from discontinued operations for the six months ending March 31, 2024[49]. - Total losses for the periods ending March 31, 2024, and March 31, 2025, were approximately HKD 16.7 million and HKD 7.0 million, respectively[50]. Assets and Liabilities - The company's total assets decreased to HKD 54,033,000 from HKD 64,092,000 as of September 30, 2024[6]. - Current liabilities decreased to HKD 25,697,000 from HKD 28,364,000, reflecting a 9% reduction[9]. - The company's equity totalled HKD 27,738,000, down from HKD 34,702,000, indicating a decline of approximately 20%[7]. - The company’s trade receivables decreased to HKD 13,121,000 as of March 31, 2025, from HKD 16,841,000 as of September 30, 2024, reflecting a 22.5% decline[36]. - The company’s trade payables decreased to HKD 6,983,000 as of March 31, 2025, from HKD 12,595,000 as of September 30, 2024, representing a 44.5% reduction[13]. - The company’s total liabilities decreased from HKD 26,446,000 as of September 30, 2024, to HKD 24,698,000 as of March 31, 2025, indicating a 6.6% reduction in overall liabilities[13]. - As of March 31, 2025, the group’s current assets net value was approximately HKD 27.7 million, down from HKD 34.9 million as of September 30, 2024[65]. Revenue Segments - The segment revenue from general construction and related services increased significantly to HKD 23,918,000 in 2025 from HKD 13,247,000 in 2024, marking a growth of approximately 80.5%[19]. - The revenue from the health management and consulting business, which has been discontinued, was HKD 17,034,000 for the six months ended March 31, 2024[25]. - The company’s revenue from external customers in Hong Kong for the six months ended March 31, 2025, was HKD 85,538,000, up from HKD 75,075,000 in 2024, showing a growth of approximately 13.1%[26]. - The group's revenue increased from approximately HKD 75.1 million to HKD 85.5 million, representing a growth of about 13.8%[43]. Cost and Expenses - The cost of sales rose from approximately HKD 69.5 million to HKD 81.8 million, an increase of about 17.7%[44]. - The group recorded a shift from gross profit to gross loss in general construction services, with a gross margin of approximately -0.2% for the period ending March 31, 2025[46]. - Administrative and other operating expenses decreased by approximately HKD 1.5 million or 10.6% to about HKD 12.6 million for the six months ending March 31, 2025[48]. - The company’s employee benefits expenses, including directors' remuneration, were HKD 10,134,000 for the six months ended March 31, 2025, down from HKD 11,128,000 in the same period of 2024, reflecting an 8.9% decrease[5]. Corporate Governance - The company has fully complied with the corporate governance code as of March 31, 2025, ensuring accountability and transparency[86]. - The audit committee, established on September 17, 2018, is responsible for reviewing financial information, internal controls, and risk management systems[87]. - The company has adhered to the listing rules regarding the composition of the audit committee, which includes at least one independent non-executive director with appropriate professional qualifications[87]. - The company emphasizes the importance of good corporate governance practices to maintain stakeholder trust and create long-term value[86]. Future Outlook and Strategy - The group plans to enhance financial resources and human resources to prepare for bidding on suitable public sector projects[42]. - The group is focusing on prudent financial management and cost control measures in response to a challenging business environment[42]. - The group continues to manage cash prudently to maintain a strong liquidity position for future growth opportunities[72]. Stock Options - The company has a stock option plan effective for ten years starting from September 17, 2018, with approximately three years remaining as of the announcement date[85]. - As of March 31, 2025, the number of stock options available for grant under the plan is 80,000,000 shares, with no options granted, exercised, expired, or canceled in the preceding six months[85]. - The company has not issued any shares under the stock option plan in the last six months, indicating no potential dilution from this plan[85].

Financial Performance - Revenue from continuing operations decreased by approximately 18.8% to about HKD 144.0 million for the year ended September 30, 2024, down from HKD 177.4 million in 2023[46] - Gross profit fell by approximately 67.4% to about HKD 9.9 million for the year ended September 30, 2024, compared to HKD 30.4 million in 2023[46] - The annual loss for the year ended September 30, 2024, is approximately HKD 10.1 million, compared to a loss of HKD 2.6 million in 2023[46] - The operating loss for the year was HKD 23,155,000 compared to an operating profit of HKD 335,000 in the previous year[57] - The loss from continuing operations for the year was HKD 23,360,000, compared to a profit of HKD 129,000 in the previous year[57] - The total comprehensive loss for the year was HKD 11,019,000, compared to HKD 2,287,000 in the previous year[57] - The company reported a basic and diluted loss per share of HKD 2.92 for continuing operations, compared to a profit of HKD 0.02 in the previous year[63] - The group reported a pre-tax loss of HKD 26.4 million for the period, compared to a loss of HKD 2.7 million for the previous year[149] Revenue Breakdown - Revenue from foundation and site formation engineering decreased to HKD 42,310,000 from HKD 83,859,000, a decline of 49.6%[74] - Revenue from general construction and related services fell to HKD 24,945,000 from HKD 41,419,000, a decrease of 39.7%[74] - Revenue from health management and consulting business dropped from approximately HKD 48.5 million for the year ended September 30, 2023, to about HKD 17.1 million for the year ended September 30, 2024[161] - Total revenue from continuing operations was HKD 161,009,000, with segment revenues including HKD 42,310,000 from foundation and site works[115] Financial Position - The total equity attributable to the owners of the company as of September 30, 2024, is approximately HKD 34.7 million, down from HKD 45.7 million in 2023[2] - The total debt of the group, including bank borrowings and lease liabilities, is approximately HKD 2.9 million as of September 30, 2024, compared to HKD 50.5 million in 2023[2] - The capital debt ratio as of September 30, 2024, is approximately 8.5%, significantly improved from 117.1% in 2023[3] - The net current assets as of September 30, 2024, are approximately HKD 34.9 million, an increase from HKD 27.0 million in 2023[33] - The company's cash and cash equivalents were HKD 41,450 million as of September 30, 2024, compared to HKD 32,558 million in 2023, indicating improved liquidity[86] - The company's net current assets increased to HKD 34,909 million in 2024 from HKD 26,970 million in 2023, reflecting better short-term financial health[88] - The total liabilities decreased to HKD 158,651 million in 2024 from HKD 29,390 million in 2023, indicating improved financial stability[88] Operational Changes - The company has undergone a name change from "Ri Ying Holdings Limited" to "Shing Chi Holdings Limited" as of August 1, 2024[67] - The company plans to focus on expanding its construction services in Hong Kong and mainland China, aiming to capture more market share[106] - The company has initiated new strategies to mitigate risks associated with its health management and consulting business, including divestiture[108] - The group plans to cease its health management business in China following the sale of its subsidiary for HKD 50,000[161] - The group aims to continue exploring suitable business opportunities and investment prospects to drive growth despite a challenging market environment[162] Cost Management - The total employee cost for the year ended September 30, 2024, is approximately HKD 43.8 million, up from HKD 38.6 million in 2023[39] - The group recorded an administrative and other operating expense of HKD 75,227,000, leading to a pre-tax loss of HKD 2,533,000[120] - Administrative and other operating expenses decreased from HKD 46.2 million in the previous year to HKD 40.0 million in the current period[149] - Administrative and other operating expenses increased by approximately HKD 4.1 million or 14.0% to about HKD 33.3 million for the year ending September 30, 2024, mainly due to impairment losses on property, plant, and equipment[181] Market Conditions - The group anticipates ongoing challenges from intense market competition, rising material and labor costs, and cautious customer budgeting in the short term[162] - The group confirmed approximately HKD 175.3 million as revenue from ongoing projects as of September 30, 2024[160] - The group had 25 construction projects on hand as of September 30, 2024, with a total contract value of approximately HKD 324.6 million, down from HKD 341.4 million in 2023[160] Asset Management - The company's financial assets and contract assets impairment loss was HKD 115,000, a significant decrease from HKD 1,640,000 in the previous year[122] - The company's trade receivables aged 0 to 30 days decreased to HKD 5,729,000 from HKD 11,320,000 year-over-year[129] - Trade receivables decreased from HKD 25.0 million in 2023 to HKD 16.8 million in 2024, with an impairment loss provision of HKD 5.1 million[152] - Contract assets decreased from approximately HKD 34.2 million as of September 30, 2023, to approximately HKD 17.7 million as of September 30, 2024, primarily due to a reduction in unbilled revenue from completed projects[184] Shareholder Returns - The company does not recommend the payment of any final dividend for the year ended September 30, 2024[34] - The company did not recommend a final dividend for the years ended September 30, 2024, and 2023[127]

Financial Performance - For the six months ended March 31, 2024, total revenue was HKD 92.1 million, compared to HKD 107.6 million for the same period in 2023, representing a decrease of approximately 14.4%[29]. - Revenue for the six months ended March 31, 2024, was HKD 92,109 thousand, a decrease of 14.4% compared to HKD 107,635 thousand for the same period in 2023[43]. - The revenue from foundation and site formation works was HKD 24.3 million, accounting for 26.4% of total revenue, compared to 51.1% in the previous period[29]. - Revenue from foundation and site preparation engineering was HKD 24,349,000, down 55.7% from HKD 54,988,000 in the prior year[107]. - Revenue from health management and consulting business, including health product sales, was HKD 17,034,000, a decrease of 13.8% from HKD 19,760,000 in the previous year[107]. - The company recorded other income of HKD 2,137,000, significantly lower than HKD 7,471,000 in the same period last year[84]. - The company reported a pre-tax loss of HKD 16,674,000 for the six months ended March 31, 2024, compared to a pre-tax loss of HKD 35,577,000 in the previous year[111]. - The net loss for the period was HKD 16,674 thousand, compared to a net loss of HKD 10,293 thousand in the previous year, indicating a significant increase in losses[44]. - Basic and diluted loss per share was HKD 2.11, compared to HKD 1.31 for the same period last year, representing a 61% increase in loss per share[44]. - The total comprehensive expense for the period attributable to owners of the company was HKD 17,004 thousand, compared to HKD 10,808 thousand in the previous year, indicating a 57.5% increase[44]. Financial Position - As of March 31, 2024, the total equity attributable to owners was approximately HKD 28.7 million, down from HKD 45.7 million as of September 30, 2023[5]. - The total debt of the group was approximately HKD 34.7 million, a decrease from HKD 50.5 million as of September 30, 2023[5]. - Total assets decreased from HKD 201,822 million as of September 30, 2023, to HKD 153,397 million as of March 31, 2024, representing a decline of approximately 24%[69]. - Total liabilities decreased from HKD 158,651 million to HKD 127,044 million, a reduction of about 20%[70]. - The company's equity attributable to owners decreased from HKD 45,664 million to HKD 28,660 million, a decline of approximately 37%[68]. - Cash and cash equivalents decreased from HKD 50,353 million to HKD 29,687 million, a drop of around 41%[74]. - The company has a net current asset value of HKD 8,644 million as of March 31, 2024, compared to HKD 26,970 million as of September 30, 2023[70]. - The company's current liabilities included trade and other payables amounting to HKD 89,365 million, down from HKD 106,097 million[70]. - The company has trade payables to related parties amounting to approximately HKD 6,375,000 as of March 31, 2024, compared to HKD 4,774,000 as of September 30, 2023[148]. Cash Flow - The company reported a net cash outflow of HKD 29,687 thousand for the six months ended March 31, 2024, compared to an inflow of HKD 50,353 thousand in the same period last year[54]. - The net cash used in operating activities was HKD 10,003 million for the six months ended March 31, 2024, compared to a net cash used of HKD 39,885 million in the same period last year[74]. - The company reported a loss of HKD 16,885 million for the current period, compared to a loss of HKD 10,484 million in the previous period[71]. Operational Updates - The group had available bank financing of approximately HKD 9.0 million as of March 31, 2024, which was not available as of September 30, 2023[5]. - The company is currently evaluating the impact of a suspended executive director on the group and will seek legal advice on the matter[11]. - The group has secured performance guarantees for contracts amounting to approximately HKD 5.6 million as of March 31, 2024, compared to HKD 3.6 million as of September 30, 2023[168]. - The group has increased its workforce by hiring two project managers, two project engineers, and other key personnel to enhance operational capacity[181]. - The number of employees increased to 210 as of March 31, 2024, up from 172 as of March 31, 2023, primarily due to recruitment for the development of health management and consulting services[196]. - The group is currently facing a dispute regarding unpaid amounts from a school construction project, which has not yet been resolved through mediation[189]. Future Outlook - The group plans to adopt prudent financial management and cost control measures in response to the uncertain business environment, including geopolitical tensions and high interest rates[171]. - The group continues to seek additional licenses and enhance its financial resources to prepare for bidding on suitable public sector projects[171]. - The group plans to utilize the net proceeds in accordance with the purposes outlined in the prospectus, with full utilization expected by September 30, 2024[199]. Investments and Acquisitions - The group did not hold any significant investments, acquisitions, or disposals of subsidiaries, associates, or joint ventures during the reporting period[7]. - The company has not made any significant acquisitions or disposals of subsidiaries, associates, or joint ventures during the reporting period[191]. - The company acquired property, plant, and equipment at a cost of approximately HKD 813,000 during the period, up from HKD 506,000 in the previous year[96]. - The company has acquired a drilling pile driver, a rock-embedded pile driver, and two air compressors, with a total expenditure of approximately HKD 30.3 million allocated for general working capital[159]. Employee Costs - The total employee cost for the six months ended March 31, 2024, was approximately HKD 24.2 million, reflecting an increase in workforce and associated costs[196]. - Employee benefits expenses, including director remuneration, increased to HKD 24,234,000 from HKD 16,151,000 year-on-year[92].

Revenue Performance - Total revenue for the six months ended March 31, 2024, was HK$92.109 million, compared to HK$107.635 million in the same period last year[32] - Revenue from foundation and site formation works decreased to HK$24.349 million from HK$54.988 million year-over-year[32] - Revenue from other construction works increased significantly to HK$32.508 million from HK$12.324 million in the previous year[32] - Sales of health products generated HK$17.034 million in revenue, down from HK$19.760 million in the prior year[32] - Revenue decreased by 14.4% to HK$92.1 million in the six months ended March 31, 2024, compared to HK$107.6 million in the same period last year[68] - Revenue from foundation and site formation works decreased to HKD 24.349 million (26.4% of total revenue) in 2024 from HKD 54.988 million (51.1% of total revenue) in 2023[85] - Revenue from the health management and consulting business decreased from HKD 19.8 million for the six months ended March 31, 2023, to HKD 17.0 million for the six months ended March 31, 2024[131] - The company's total revenue for the six months ended March 31, 2024, was HKD 92.109 million, compared to HKD 107.635 million for the same period in 2023[142] Profit and Loss - Gross profit decreased by 6.4% to HK$17.6 million, with gross margin improving to 19.2% from 17.5% in the previous year[70] - Operating loss widened to HK$15.6 million from HK$9.8 million in the prior period[50] - Net loss attributable to the company's owners increased to HK$16.9 million from HK$10.5 million[52] - Basic and diluted loss per share increased to 2.11 HK cents from 1.31 HK cents[53] - The group's gross profit margin for general construction and related services turned from a gross loss margin of 81.0% in 2023 to a gross profit margin of 24.8% in 2024, driven by the resumption of large-scale projects and the absence of further losses from a disputed school reconstruction project[76] - The group reported a loss of HKD 10.3 million in 2023 and HKD 16.7 million in 2024[81] - The company's loss attributable to owners increased from 10,484 to 16,885 thousand HKD, with basic loss per share rising from 1.31 to 2.11 HK cents[114] Assets and Liabilities - Total liabilities decreased to HK$127.044 million from HK$158.651 million as of September 30, 2023[12] - Net current assets stood at HK$8.644 million, a decrease from HK$26.970 million at the end of the previous fiscal period[12] - Total equity attributable to the company's owners was HK$45.664 million, with non-controlling interests at HK$(2.493) million[4] - The company's total assets less current liabilities were HK$31.660 million, down from HK$49.614 million as of September 30, 2023[12] - Total assets decreased to HK$153.4 million from HK$201.8 million as of March 31, 2024[54] - The group's non-current assets in China increased to HKD 18.062 million in 2024 from HKD 16.327 million in 2023, while assets in Hong Kong decreased to HKD 4.954 million from HKD 6.317 million[91] - The group's bank cash and balances decreased to HKD 29.687 million in 2024 from HKD 41.450 million in 2023[103] - Trade receivables overdue as of March 31, 2024, amounted to HKD 11.231 million, with HKD 2.260 million overdue for 90 days or more[102] - The group acquired property, plant, and equipment worth HKD 813,000 in 2024, compared to HKD 506,000 in 2023[98] - Trade receivables decreased from 25,006 to 18,985 thousand HKD, with a slight reduction in impairment loss provision from 4,400 to 4,431 thousand HKD[125] - Trade payables decreased significantly from 9,099 to 3,573 thousand HKD, indicating improved payment terms or reduced liabilities[121] - As of March 31, 2024, the company's net current assets were HKD 8.6 million, down from HKD 27.0 million as of September 30, 2023[152] - The company's bank balances and cash stood at HKD 29.7 million as of March 31, 2024, compared to HKD 41.5 million as of September 30, 2023[152] - The company's total equity attributable to owners was HKD 28.7 million as of March 31, 2024, down from HKD 45.7 million as of September 30, 2023[152] - The company's total debt, including bank borrowings and lease liabilities, was HKD 34.7 million as of March 31, 2024, compared to HKD 50.5 million as of September 30, 2023[152] - The company has available bank financing of HKD 9.0 million as of March 31, 2024, with none utilized as of September 30, 2023[152] - The company has pledged vehicles with a net book value of HKD 0.9 million as collateral under irrevocable lease agreements as of March 31, 2024, up from HKD 0.5 million as of September 30, 2023[154] - The company's capital-to-debt ratio increased to 131.7% as of March 31, 2024, up from 117.1% as of September 30, 2023, primarily due to an increase in bank borrowings[180] Expenses and Costs - Administrative and other operating expenses totaled HK$(35.577) million[37] - Administrative and other operating expenses remained stable at approximately HKD 35.9 million in 2023 and HKD 35.6 million in 2024[78] - Employee benefits expenses, including directors' remuneration, surged from 16,151 to 24,234 thousand HKD, indicating higher labor costs[112] - R&D costs decreased from 5,525 to 3,046 thousand HKD, suggesting a reduction in innovation spending[112] - Total employee costs for the six months ended March 31, 2024, were approximately HKD 24.2 million, compared to HKD 18.0 million in the same period last year[184] Other Income and Losses - Other income, gains, and losses amounted to HK$2.137 million, a significant drop from HK$7.471 million in the same period last year[33] - Other income, gains, and losses decreased by HKD 5.4 million from HKD 7.5 million in 2023 to HKD 2.1 million in 2024, primarily due to reduced agency commission income and the absence of a one-time legal claim compensation received in 2023[77] - The group recorded a tax expense of HKD 37,000 in 2024, compared to HKD 14,000 in 2023, mainly due to taxable profits from the China business[80] Projects and Operations - The company increased capital in two subsidiaries, Baocheng Construction Limited and Huang'an Construction Limited[67][71] - Revenue decline was primarily due to reduced projects in foundation and site formation works, general building works, and construction-related consultancy services[74] - Health management and consulting business revenue decreased due to lower sales of health intelligent robots[74] - The company has several ongoing projects with expected completion dates ranging from 2024 to 2025, indicating a robust project pipeline[123][124] - The company had 24 ongoing construction projects as of March 31, 2024, with a total contract value of HKD 203.6 million, compared to 23 projects with a total contract value of HKD 341.4 million as of September 30, 2023[129] - The company's subsidiary, Huang An Construction Limited, is involved in a dispute with a school in Hong Kong over unpaid fees for design and construction work, with arbitration proceedings ongoing[163] Financial Reporting and Compliance - The company applied new and revised Hong Kong Financial Reporting Standards during the period, including amendments to HKFRS 10 and HKAS 28[59] - The company has maintained full compliance with the Corporate Governance Code as of March 31, 2024[191] - The Audit Committee, established on September 17, 2018, reviewed the unaudited condensed consolidated financial statements for the six months ended March 31, 2024[193] - The company's board of directors includes executive directors and independent non-executive directors as of the announcement date[194] Capital and Financing - The company has utilized HKD 86.1 million of the net proceeds from its IPO as of March 31, 2024, with the remaining HKD 0.5 million expected to be fully utilized by September 30, 2024[151] - The company's net proceeds from the IPO amounted to approximately HKD 86.6 million, which have been partially utilized according to the future plans and uses of proceeds as disclosed in the prospectus[158] - The company's capital structure consists solely of ordinary shares, with no changes since its listing on the Hong Kong Stock Exchange on October 16, 2018[160] - The company has no capital commitments as of March 31, 2024, compared to none as of September 30, 2023[165] - The company's operating and investment activities are primarily funded by cash generated from operations, bank borrowings, and equity from shareholders[161] - The company has no significant investments, acquisitions, or disposals of subsidiaries, associates, or joint ventures during the six months ended March 31, 2024[178] Share Options and Employee Incentives - The company has adopted a share option plan to attract and retain qualified personnel, offering additional incentives to employees, directors, consultants, and other stakeholders[173] - The company's share option plan allows for the issuance of shares up to 10% of the total issued shares at the time of plan approval, with the limit renewable every three years[188] - The share option plan, effective from September 17, 2018, for a ten-year period, had 80,000,000 options available for grant as of March 31, 2024[200] - No share options were granted, exercised, expired, lapsed, or canceled during the six months ended March 31, 2024[200] - The company's share option plan requires shareholder approval for any grants exceeding 1% of the issued shares within any 12-month period[198] Legal and Governance Issues - The company has suspended the duties and powers of an executive director, Mr. Sun Wei, due to his alleged involvement in a potential financial fraud case under investigation in China[181][182] - The company did not buy back or redeem any of its listed securities during the six months ended March 31, 2024[185] - The company has no interim dividend declared or proposed for the six months ended March 31, 2024, consistent with the same period in 2023[169] Employee and Labor Costs - The company had 210 employees as of March 31, 2024, an increase from 172 employees in the same period last year, primarily due to recruitment for the development of health management and consulting business in China[184]